Lyric acquires Concert
The healthcare technology company converts clinical policies into machine-readable decisions used in payment-accuracy workflows.
Takeaways
- Concert is a Healthcare payment-accuracy technology company that converts clinical policies into machine-readable decisions.
- Lyric is acquiring Concert with backing from TPG Capital.
- The.
TPG Capital-backed Lyric acquired Concert, a Nashville healthcare technology company focused on precision health payment accuracy.
Concert converts clinical and administrative policies into machine-readable rules that health plans and providers can use in real-time claims decisions.
The companies have worked together since 2023 on an outpatient laboratory testing module, and Concert's technology will now be integrated across the Lyric42 healthcare decision-intelligence platform.
Lyric supports 200 million lives and serves nine of the 10 largest U.S. health plans.
Financial terms were not disclosed.
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.